Dynamk Capital
Team Portfolio Content News
CONTACT US
TeamPortfolioContentNews
Dynamk Capital
CONTACT US
 

News


 
Zebra-Building.jpg
Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology
Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology
portfolioDynamk CapitalJune 15, 2021
Dynamk Capital names Jessica Davis, Senior Associate
Dynamk Capital names Jessica Davis, Senior Associate
Dynamk CapitalMay 26, 2021
Dynamk Capital Announces Final Closing of its Life Science Industrials Fund
Dynamk Capital Announces Final Closing of its Life Science Industrials Fund
Dynamk CapitalApril 27, 2021
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
portfolioDynamk CapitalMarch 18, 2021
Dynamk Capital Promotes Sebastien Latapie to Principal
Dynamk Capital Promotes Sebastien Latapie to Principal
Dynamk CapitalJanuary 5, 2021
Dynamk Capital talks the Future of Healthcare with Pharma’s Almanac
Dynamk Capital talks the Future of Healthcare with Pharma’s Almanac
Dynamk CapitalOctober 11, 2020
Lucid Scientific Secures $3 Million in Series Seed Financing Led by Dynamk Capital
Lucid Scientific Secures $3 Million in Series Seed Financing Led by Dynamk Capital
Dynamk CapitalOctober 1, 2020
Dynamk featured in Pharma’s Almanac article on disruptive Organ-on-a-Chip
Dynamk featured in Pharma’s Almanac article on disruptive Organ-on-a-Chip
Dynamk CapitalOctober 1, 2020
Dynamk Launches Industry Insights Newsletter: Quarterly Trends, Transactions & Headlines
Dynamk Launches Industry Insights Newsletter: Quarterly Trends, Transactions & Headlines
Dynamk CapitalJuly 13, 2020
Dr. Gustavo Mahler Now a General Partner at Dynamk Capital
Dr. Gustavo Mahler Now a General Partner at Dynamk Capital
Dynamk CapitalApril 7, 2020
CellFE Closes $4.8M Seed Round Funding Co-led by Dynamk Capital and Cota Capital
CellFE Closes $4.8M Seed Round Funding Co-led by Dynamk Capital and Cota Capital
portfolioDynamk CapitalMarch 31, 2020
Pharma's Almanac Article: Facilitating the Commercialization of Disruptive Industrial Life Science Technologies
Pharma's Almanac Article: Facilitating the Commercialization of Disruptive Industrial Life Science Technologies
Daniella KranjacMarch 19, 2020
CellFE Raises $3.6 Million in Series Seed Round Co-Led by Dynamk Capital and Cota Capital
CellFE Raises $3.6 Million in Series Seed Round Co-Led by Dynamk Capital and Cota Capital
portfolioDynamk CapitalJanuary 16, 2020
Dynamk Capital participates in Life Science Investor Panel during JPMorgan Healthcare Week
Dynamk Capital participates in Life Science Investor Panel during JPMorgan Healthcare Week
Daniella KranjacJanuary 10, 2020
Dynamk Capital sponsors Life Sciences Washington VIP Forum
Dynamk Capital sponsors Life Sciences Washington VIP Forum
Dynamk CapitalNovember 5, 2019
FloDesign Sonics Acquired by MilliporeSigma
FloDesign Sonics Acquired by MilliporeSigma
portfolioDynamk CapitalOctober 10, 2019
RoosterBio Raises $15 Million in Series B Round Led by Dynamk Capital
RoosterBio Raises $15 Million in Series B Round Led by Dynamk Capital
portfolioDynamk CapitalAugust 6, 2019
Dr. Gustavo Mahler joins Dynamk Capital as Venture Partner
Dr. Gustavo Mahler joins Dynamk Capital as Venture Partner
Dynamk CapitalMay 29, 2019
Dynamk Capital names Sebastien Latapie, Senior Venture Associate
Dynamk Capital names Sebastien Latapie, Senior Venture Associate
Dynamk CapitalMay 27, 2019
Dynamk Capital Announces New Partner, Reinhard Vogt
Dynamk Capital Announces New Partner, Reinhard Vogt
Dynamk CapitalJanuary 7, 2019
Newer Older
Dynamk Capital LLC
30 Wall Street, 12th floor,
New York, NY, 10005,
United States
Hours
HomeTeamPortfolioContentNewsContact Us

DYNAMK CAPITAL LLC
©2016-2024. All rights reserved. 
Disclaimer